FDA’s Surgical Robot Guidance Prefers Robotic Comparator Data, Which Mostly Means Measuring Challengers Against Intuitive
One test for every surgical robot, and by preferring robotic comparators it decides whose results set the score.
NeuroPulse
DealPulse Signal
The Beats
Analysis
The Briefs
FDA’s Surgical Robot Guidance Prefers Robotic Comparator Data, Which Mostly Means Measuring Challengers Against Intuitive
Qatar Became Foundayo’s Sixth Market as Lilly Claimed an Edge Over Oral Semaglutide 25 mg
IQWiG and LSE Authors Say EU Joint Clinical Assessments Could Become a Basis for US Price Talks
The plan lowers the evidence bar at launch and moves the proof to later real-world data, where insurers doubt it exists.
Novo Paid $300 Million Upfront for a Weekly GLP-1/GIP Pill That Has Not Yet Entered Phase 1